Mobetron Makes Groundbreaking Radiation Therapy Technique a Reality for Japanese Breast Cancer Patients

Nagoya University Hospital joins the European Institute of Oncology in making single-dose intraoperative electron-beam radiation therapy (IOERT) a key part of their breast cancer treatment protocol

SUNNYVALE, Calif. — IntraOp Medical Corporation (OTCBB: IOPM), announced today that doctors at Nagoya University Hospital in Nagoya, Japan, are now using the Mobetron to deliver intraoperative electron-beam radiation therapy (IOERT) to breast cancer patients. The Mobetron allows Nagoya University Hospital to employ the groundbreaking single-dose technique, a treatment that offers substantial physiological and psychological benefits to breast cancer patients.

Nagoya University Hospital acquired the Mobetron, IntraOp Medical's mobile, self-shielding linear accelerator, in October, 2006. Nagoya University has had a long and distinguished history of using IOERT through patient transportation, particularly for the treatment of pancreatic cancer.

source: centredaily.com